Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06921902 · ClinicalTrials.gov registry record

Glycemic Metrics and Patterns in People With and Without Prediabetes

A clinical trial of Pre Diabetes, sponsored by Abbott Diabetes Care.

Recruiting
Registry status
2,000
Enrollment target
1
Study location

NCT06921902 is a study of Pre Diabetes that is actively recruiting participants, run by Abbott Diabetes Care. The registered enrollment target is 2,000 participants, above the 696-participant average among 59 other Pre Diabetes trials with a reported enrollment target (187% higher). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06921902, a study of Pre Diabetes, is actively recruiting participants, sponsored by Abbott Diabetes Care.

RECRUITING
Registry status
2,000 participants
Enrollment target
1
Study location

Study Summary

The FreeStyle Libre 3 Continuous Glucose Monitoring (FSL3) System is used to characterize the glycemic profiles of people with and without a prediabetes diagnosis.

Conditions Studied

Interventions

  • DEVICE FreeStyle Libre 3

Study Locations (1)

Oregon

  • Diabetes and Obesity Care - Bend

Trial Details

FieldValue
Enrollment Target 2,000 participants
Start Date 2025-02-28
Est. Completion 2026-07

Sponsor

Abbott Diabetes Care

26 total trials

What the Registry Record Tells You About NCT06921902

The ClinicalTrials.gov registry entry for NCT06921902 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 2,000 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 696-participant average among 59 other Pre Diabetes trials with a reported enrollment target (187% higher). The listed sponsor is Abbott Diabetes Care, which has 26 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Pre Diabetes appearing as the primary indexed condition, and to 1 intervention - of which FreeStyle Libre 3 is the first listed.

NCT06921902 reports 1 study location spanning 1 distinct geographic area - top geographies include Oregon.

Frequently Asked Questions

What is clinical trial NCT06921902 about?

NCT06921902 is a clinical study titled "Glycemic Metrics and Patterns in People With and Without Prediabetes". The FreeStyle Libre 3 Continuous Glucose Monitoring (FSL3) System is used to characterize the glycemic profiles of people with and without a prediabetes diagnosis.

What is the current status of trial NCT06921902?

This trial is currently recruiting. The enrollment target is 2,000 participants. The study started on 2025-02-28. Estimated completion is 2026-07.

What conditions does trial NCT06921902 study?

This clinical trial studies the following conditions: Pre Diabetes.

What interventions are being tested in trial NCT06921902?

The interventions under investigation include: FreeStyle Libre 3 (DEVICE).

Who is sponsoring clinical trial NCT06921902?

This trial is sponsored by Abbott Diabetes Care, which has 26 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06921902 being conducted?

This trial has 1 study location across Oregon. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Pre Diabetes

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.